Prevalence was higher for men than women, increased with income, and varied from 10.5 percent in Utah to 25.8 percent in Wisconsin

0.7 million of 2.4 million U.S. adults misused buprenorphine in 2019; motivations for misuse include being hooked, physical pain relief

COVID-19 standardized mortality rates were elevated across nine psychiatric conditions including learning disabilities, eating disorders

FDA has not had a permanent head for more than eight months, is being overseen by Acting Commissioner Janet Woodcock